Motif-programmed artificial protein induces apoptosis in several cancer cells by disrupting mitochondria

Cancer Science

Volumn 99, Issue 2, 2008, Pages 398-406

  Saito, Hirohide ^a,b,c,d   Minamisawa, Tamiko ^a   Yamori, Takao ^e   Shiba, Kiyotaka ^a,b  

^a CANCER INSTITUTE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d Japan Science and Technology Agency   (Japan)

^e CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; PROTEIN 284; PROTEIN BAX; PROTEIN NOXA; SYNTHETIC PEPTIDE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CELL AGGREGATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MITOCHONDRION; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN SYNTHESIS;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; HUMANS; IN SITU NICK-END LABELING; MITOCHONDRIA; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; PROTEIN ENGINEERING; PROTEINS; RECOMBINANT FUSION PROTEINS;

EID: 38949185682     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00697.x     Document Type: Article

References (20)

1. Benner SA, Sismour AM. Synthetic biology. Nat Rev Genet 2005; 6: 533-43.
2. Endy D. Foundations for engineering biology. Nature 2005; 438: 449-53.
3. Shiba K, Takahashi Y, Noda T. On the role of periodism in the origin of proteins. J Mol Biol 2002; 320: 833-40.
4. Shiba K. Molcraft: A hierarchical approach to the synthesis of artificial proteins. J Mol Catal B 2004; 28: 145-53.
5. Saito H, Honma T, Minamisawa T et al. Synthesis of functional proteins by mixing peptide motifs. Chem Biol 2004; 11: 765-73.
6. Shiba K, Honma T, Minamisawa T, Nishiguchi K, Noda T. Distinct macroscopic structures developed from solutions of chemical compounds and periodic proteins. EMBO Rep 2003; 4: 148-53.
7. Saito H, Minamisawa T, Shiba K. Motif programming: A microgene-based method for creating synthetic proteins containing multiple functional motifs. Nucleic Acids Res 2007; 35: E38.
8. Kitano H. Systems biology: A brief overview. Science 2002; 295: 1662-4.
9. Frugier M, Giege R, Schimmel P. RNA recognition by designed peptide fusion creates 'artificial'tRNA synthetase. Proc Natl Acad Sci U S A 2003; 100: 7471-5.
10. Paull KD, Shoemaker RH, Hodes L et al. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J Natl Cancer Inst 1989; 81: 1088-92.
11. Skehan P, Storeng R, Scudiero D et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82: 1107-12.
12. Yamori T, Matsunaga A, Sato S et al. Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel. Cancer Res 1999; 59: 4042-9.
13. Yaguchi S, Fukui Y, Koshimizu I et al. Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor. J Natl Cancer Inst 2006; 98: 545-56.
14. Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000; 10: 369-77.
15. Green DR. Apoptotic pathways. ten minutes to dead. Cell 2005; 121: 671-4.
16. Oda E, Ohki R, Murasawa H et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000; 288: 1053-8.
17. Suzuki M, Youle RJ, Tjandra N. Structure of Bax: Coregulation of dimer formation and intracellular localization. Cell 2000; 103: 645-54.
18. Zafir-Lavie I, Michaeli Y, Reiter Y. Novel antibodies as anticancer agents. Oncogene 2007; 26: 3714-33.
19. Haga N, Fujita N, Tsuruo T. Mitochondrial aggregation precedes cytochrome c release from mitochondria during apoptosis. Oncogene 2003; 22: 5579-85.
20. Seo YW, Shin JN, Ko KH et al. The molecular mechanism of Noxa-induced mitochondrial dysfunction in p53-mediated cell death. J Biol Chem 2003; 278: 48292-9.